Target Price | $10.76 |
Price | $2.98 |
Potential |
261.07%
register free of charge
|
Number of Estimates | 10 |
10 Analysts have issued a price target Autolus Therapeutics plc 2025 .
The average Autolus Therapeutics plc target price is $10.76.
This is
261.07%
register free of charge
$13.00
336.24%
register free of charge
$7.60
155.03%
register free of charge
|
|
A rating was issued by 11 analysts: 11 Analysts recommend Autolus Therapeutics plc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Autolus Therapeutics plc stock has an average upside potential 2025 of
261.07%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 1.70 | 14.47 |
72.54% | 751.31% | |
EBITDA Margin | -11,085.88% | -1,366.42% |
328.32% | 87.67% | |
Net Margin | -18,784.94% | -1,577.61% |
178.31% | 91.60% |
10 Analysts have issued a sales forecast Autolus Therapeutics plc 2024 . The average Autolus Therapeutics plc sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Autolus Therapeutics plc EBITDA forecast 2024. The average Autolus Therapeutics plc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Autolus Therapeutics plc Analysts have issued a net profit forecast 2024. The average Autolus Therapeutics plc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.20 | -0.86 |
23.57% | 28.33% | |
P/E | negative | |
EV/Sales | 30.10 |
5 Analysts have issued a Autolus Therapeutics plc forecast for earnings per share. The average Autolus Therapeutics plc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Autolus Therapeutics plc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Autolus Therapeutics plc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.